BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 410627 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CC3CC3C2)cc1Cl InChI=1S/C23H24ClN7O2/c1-33-19-4-3-14(7-18(19)24)9-27-21-17(22(32)28-11-20-25-5-2-6-26-20)10-29-23(30-21)31-12-15-8-16(15)13-31/h2-7,10,15-16H,8-9,11-13H2,1H3,(H,28,32)(H,27,29,30) MZTKPBZVHILACH-UHFFFAOYSA-N 235733 US9359371, 1 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 6.04 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235733&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214471 340129326 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410628 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccn2)N2CC3CC3C2)cc1Cl InChI=1S/C24H25ClN6O2/c1-33-21-6-5-15(8-20(21)25)10-27-22-19(23(32)28-11-18-4-2-3-7-26-18)12-29-24(30-22)31-13-16-9-17(16)14-31/h2-8,12,16-17H,9-11,13-14H2,1H3,(H,28,32)(H,27,29,30) BCJVQQJQFQTUGB-UHFFFAOYSA-N 235734 US9359371, 2 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 2.12 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235734&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214472 340129327 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410629 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccc2)N2CC3CC3C2)cc1Cl InChI=1S/C25H26ClN5O2/c1-33-22-8-7-17(9-21(22)26)12-27-23-20(24(32)28-11-16-5-3-2-4-6-16)13-29-25(30-23)31-14-18-10-19(18)15-31/h2-9,13,18-19H,10-12,14-15H2,1H3,(H,28,32)(H,27,29,30) QFAMNDUERIPOEM-UHFFFAOYSA-N 235735 US9359371, 3 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 12.88 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235735&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214473 340129328 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410630 COc1ccc(CNc2nc(ncc2C(=O)NCc2cnc(C)cn2)N2CC3CC3C2)cc1Cl InChI=1S/C24H26ClN7O2/c1-14-7-27-18(9-26-14)10-29-23(33)19-11-30-24(32-12-16-6-17(16)13-32)31-22(19)28-8-15-3-4-21(34-2)20(25)5-15/h3-5,7,9,11,16-17H,6,8,10,12-13H2,1-2H3,(H,29,33)(H,28,30,31) YTGPPIXKPISAKT-UHFFFAOYSA-N 235736 US9359371, 4 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 4.63 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235736&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214543 340129329 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410631 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccc(F)cc2)N2CC3CC3C2)cc1Cl InChI=1S/C25H25ClFN5O2/c1-34-22-7-4-16(8-21(22)26)11-28-23-20(24(33)29-10-15-2-5-19(27)6-3-15)12-30-25(31-23)32-13-17-9-18(17)14-32/h2-8,12,17-18H,9-11,13-14H2,1H3,(H,29,33)(H,28,30,31) UXSJCOGGAQEECN-UHFFFAOYSA-N 235737 US9359371, 5 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.4 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235737&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214544 340129330 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410632 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCOCC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H31ClN6O3/c1-33-21-3-2-16(10-20(21)25)12-27-22-19(23(32)26-4-5-30-6-8-34-9-7-30)13-28-24(29-22)31-14-17-11-18(17)15-31/h2-3,10,13,17-18H,4-9,11-12,14-15H2,1H3,(H,26,32)(H,27,28,29) JYGJLOZZTXETOG-UHFFFAOYSA-N 235738 US9359371, 6 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 4.25 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235738&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214321 340129331 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410633 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CCCCNC2=O)N2CC3CC3C2)cc1Cl InChI=1S/C24H29ClN6O3/c1-34-20-6-5-14(8-18(20)25)10-27-21-17(22(32)29-19-4-2-3-7-26-23(19)33)11-28-24(30-21)31-12-15-9-16(15)13-31/h5-6,8,11,15-16,19H,2-4,7,9-10,12-13H2,1H3,(H,26,33)(H,29,32)(H,27,28,30)/t15?,16?,19-/m0/s1 WZVAWCCERLVMTA-RJYAGPCLSA-N 235740 US9359371, 8 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 13.2 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235740&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214392 340129333 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410634 COc1ccc(CNc2nc(ncc2C(=O)NC2CCCCCC2)N2CC3CC3C2)cc1Cl InChI=1S/C25H32ClN5O2/c1-33-22-9-8-16(10-21(22)26)12-27-23-20(24(32)29-19-6-4-2-3-5-7-19)13-28-25(30-23)31-14-17-11-18(17)15-31/h8-10,13,17-19H,2-7,11-12,14-15H2,1H3,(H,29,32)(H,27,28,30) FOCZLKMINJBXND-UHFFFAOYSA-N 235741 US9359371, 9 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 23.2 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235741&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214115 340129334 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410635 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H30ClN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- NKAVILAJSNUOES-VNGAXPGBSA-N 235742 US9359371, 11 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 4.02 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235742&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214113 340129335 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410636 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC3(CC3)CC2)cc1Cl InChI=1S/C25H28ClN7O2/c1-35-20-4-3-17(13-19(20)26)14-29-22-18(23(34)30-16-21-27-9-2-10-28-21)15-31-24(32-22)33-11-7-25(5-6-25)8-12-33/h2-4,9-10,13,15H,5-8,11-12,14,16H2,1H3,(H,30,34)(H,29,31,32) BMDHRXZKXUVMEA-UHFFFAOYSA-N 235744 US9359371, 15 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 26.76 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235744&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214547 340129337 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410637 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccc2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C26H28ClN5O2/c1-34-22-8-7-19(13-21(22)27)15-28-23-20(24(33)29-14-18-5-3-2-4-6-18)16-30-25(31-23)32-12-11-26(17-32)9-10-26/h2-8,13,16H,9-12,14-15,17H2,1H3,(H,29,33)(H,28,30,31) ABZWMNDSERNZJI-UHFFFAOYSA-N 235746 US9359371, 21 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.31 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235746&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213540 340129339 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410638 COc1ncc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CC3CC3C2)cc1Cl InChI=1S/C22H23ClN8O2/c1-33-21-17(23)5-13(8-28-21)7-26-19-16(20(32)27-10-18-24-3-2-4-25-18)9-29-22(30-19)31-11-14-6-15(14)12-31/h2-5,8-9,14-15H,6-7,10-12H2,1H3,(H,27,32)(H,26,29,30) RWYQIZKSPNYPBW-UHFFFAOYSA-N 235747 US9359371, 25 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 47.01 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235747&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 118157945 340129340 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410639 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CC3CC3C2CO)cc1Cl InChI=1S/C24H26ClN7O3/c1-35-20-4-3-14(7-18(20)25)9-28-22-17(23(34)29-11-21-26-5-2-6-27-21)10-30-24(31-22)32-12-15-8-16(15)19(32)13-33/h2-7,10,15-16,19,33H,8-9,11-13H2,1H3,(H,29,34)(H,28,30,31) YRTBOCDNCJABSN-UHFFFAOYSA-N 235748 US9359371, 27 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 10.39 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235748&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213601 340129341 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410640 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccc2)N2CCC3(CCC3)C2)cc1Cl InChI=1S/C27H30ClN5O2/c1-35-23-9-8-20(14-22(23)28)16-29-24-21(25(34)30-15-19-6-3-2-4-7-19)17-31-26(32-24)33-13-12-27(18-33)10-5-11-27/h2-4,6-9,14,17H,5,10-13,15-16,18H2,1H3,(H,30,34)(H,29,31,32) VBYXHYAABPFDES-UHFFFAOYSA-N 235749 US9359371, 28 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 22.65 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235749&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213602 340129342 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410641 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccc2)N2CC3CC3C2CO)cc1Cl InChI=1S/C26H28ClN5O3/c1-35-23-8-7-17(9-21(23)27)12-28-24-20(25(34)29-11-16-5-3-2-4-6-16)13-30-26(31-24)32-14-18-10-19(18)22(32)15-33/h2-9,13,18-19,22,33H,10-12,14-15H2,1H3,(H,29,34)(H,28,30,31) QTUWHCRYSKMASA-UHFFFAOYSA-N 235750 US9359371, 32 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 4.63 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235750&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213539 340129343 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410642 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCOCC2)N2CC3CC3C2CO)cc1Cl InChI=1S/C25H33ClN6O4/c1-35-22-3-2-16(10-20(22)26)12-28-23-19(24(34)27-4-5-31-6-8-36-9-7-31)13-29-25(30-23)32-14-17-11-18(17)21(32)15-33/h2-3,10,13,17-18,21,33H,4-9,11-12,14-15H2,1H3,(H,27,34)(H,28,29,30) USSKBORNVGKXTA-UHFFFAOYSA-N 235751 US9359371, 34 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 34.88 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235751&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214395 340129344 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410643 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2CO)cc1Cl InChI=1S/C25H32ClN5O4/c1-35-22-7-2-14(8-20(22)26)10-27-23-19(24(34)29-16-3-5-17(33)6-4-16)11-28-25(30-23)31-12-15-9-18(15)21(31)13-32/h2,7-8,11,15-18,21,32-33H,3-6,9-10,12-13H2,1H3,(H,29,34)(H,27,28,30)/t15?,16-,17-,18?,21? RHXDUELMGFLMLW-LVVNJQOBSA-N 235752 US9359371, 35 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 47.22 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235752&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214114 340129345 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410644 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CCC3(CC3)CC2)cc1Cl InChI=1S/C26H34ClN5O3/c1-35-22-7-2-17(14-21(22)27)15-28-23-20(24(34)30-18-3-5-19(33)6-4-18)16-29-25(31-23)32-12-10-26(8-9-26)11-13-32/h2,7,14,16,18-19,33H,3-6,8-13,15H2,1H3,(H,30,34)(H,28,29,31)/t18-,19- NBNIZWJPQITUQV-WGSAOQKQSA-N 235753 US9359371, 36 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 52.42 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235753&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214116 340129346 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410645 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccn2)N2CC3CC3C2CO)cc1Cl InChI=1S/C25H27ClN6O3/c1-35-22-6-5-15(8-20(22)26)10-28-23-19(24(34)29-11-17-4-2-3-7-27-17)12-30-25(31-23)32-13-16-9-18(16)21(32)14-33/h2-8,12,16,18,21,33H,9-11,13-14H2,1H3,(H,29,34)(H,28,30,31) YHMXVWGUBAXSRE-UHFFFAOYSA-N 235754 US9359371, 37 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 33.33 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235754&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213604 340129347 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410646 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCOCC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H33ClN6O3/c1-34-21-3-2-18(14-20(21)26)15-28-22-19(23(33)27-7-9-31-10-12-35-13-11-31)16-29-24(30-22)32-8-6-25(17-32)4-5-25/h2-3,14,16H,4-13,15,17H2,1H3,(H,27,33)(H,28,29,30) VGOIJQQFKMYKNH-UHFFFAOYSA-N 235756 US9359371, 39 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 21.37 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235756&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214185 340129349 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410647 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccn2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H27ClN6O2/c1-34-21-6-5-17(12-20(21)26)13-28-22-19(23(33)29-14-18-4-2-3-10-27-18)15-30-24(31-22)32-11-9-25(16-32)7-8-25/h2-6,10,12,15H,7-9,11,13-14,16H2,1H3,(H,29,33)(H,28,30,31) YSBLUIPEYGCASH-UHFFFAOYSA-N 235757 US9359371, 40 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 11.88 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235757&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213675 340129350 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410648 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C24H26ClN7O2/c1-34-19-4-3-16(11-18(19)25)12-28-21-17(22(33)29-14-20-26-8-2-9-27-20)13-30-23(31-21)32-10-7-24(15-32)5-6-24/h2-4,8-9,11,13H,5-7,10,12,14-15H2,1H3,(H,29,33)(H,28,30,31) BACLRPFZQCWHJH-UHFFFAOYSA-N 235758 US9359371, 41 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 22.91 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235758&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73213605 340129351 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410649 COc1ccc(CNc2nc(ncc2C(=O)N[C@@H]2CC[C@H](O)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H32ClN5O3/c1-34-21-7-2-16(12-20(21)26)13-27-22-19(23(33)29-17-3-5-18(32)6-4-17)14-28-24(30-22)31-11-10-25(15-31)8-9-25/h2,7,12,14,17-18,32H,3-6,8-11,13,15H2,1H3,(H,29,33)(H,27,28,30)/t17-,18+ SYXJXPIARFJMEF-HDICACEKSA-N 235760 US9359371, 43 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 15.4 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235760&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214182 340129353 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410650 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCN(C)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C26H36ClN7O2/c1-32-11-13-33(14-12-32)10-8-28-24(35)20-17-30-25(34-9-7-26(18-34)5-6-26)31-23(20)29-16-19-3-4-22(36-2)21(27)15-19/h3-4,15,17H,5-14,16,18H2,1-2H3,(H,28,35)(H,29,30,31) WXVWOXLABRWNAU-UHFFFAOYSA-N 235762 US9359371, 46 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 14.9 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235762&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214470 340129355 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410651 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 12.25 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410652 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410653 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 9.29 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410654 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410655 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410656 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410657 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410658 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410659 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 17.32 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410660 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 12.53 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410661 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 10.77 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410662 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 10.77 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410663 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 10.77 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410664 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 10.77 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410665 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 10.77 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410666 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 20.86 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410667 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 20.86 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410668 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 20.86 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410669 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 20.86 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410670 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 26.04 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410671 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 26.04 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410672 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 26.04 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410673 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 8.557 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410674 COc1ccc(CN=c2[nH]c(ncc2C(O)=NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 WEAJZXNPAWBCOA-INIZCTEOSA-N 235766 US9359371, Avanafil cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 6.993 7.5 US Patent 10.7270/Q2BR8R2B aid1803046 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235766&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 129012254 340129359 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410675 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CC3CC3C2)cc1Cl InChI=1S/C23H24ClN7O2/c1-33-19-4-3-14(7-18(19)24)9-27-21-17(22(32)28-11-20-25-5-2-6-26-20)10-29-23(30-21)31-12-15-8-16(15)13-31/h2-7,10,15-16H,8-9,11-13H2,1H3,(H,28,32)(H,27,29,30) MZTKPBZVHILACH-UHFFFAOYSA-N 235733 US9359371, 1 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 6.04 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235733&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214471 340129326 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410676 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccc2)N2CC3CC3C2)cc1Cl InChI=1S/C25H26ClN5O2/c1-33-22-8-7-17(9-21(22)26)12-27-23-20(24(32)28-11-16-5-3-2-4-6-16)13-29-25(30-23)31-14-18-10-19(18)15-31/h2-9,13,18-19H,10-12,14-15H2,1H3,(H,28,32)(H,27,29,30) QFAMNDUERIPOEM-UHFFFAOYSA-N 235735 US9359371, 3 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 0.91 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235735&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214473 340129328 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410677 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H30ClN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- NKAVILAJSNUOES-VNGAXPGBSA-N 235742 US9359371, 11 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 1.31 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235742&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214113 340129335 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410678 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H32ClN5O3/c1-34-21-7-2-16(12-20(21)26)13-27-22-19(23(33)29-17-3-5-18(32)6-4-17)14-28-24(30-22)31-11-10-25(15-31)8-9-25/h2,7,12,14,17-18,32H,3-6,8-11,13,15H2,1H3,(H,29,33)(H,27,28,30)/t17-,18- SYXJXPIARFJMEF-IYARVYRRSA-N 235755 US9359371, 38 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 0.8 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235755&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214182 340129348 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410679 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCN(C)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C26H36ClN7O2/c1-32-11-13-33(14-12-32)10-8-28-24(35)20-17-30-25(34-9-7-26(18-34)5-6-26)31-23(20)29-16-19-3-4-22(36-2)21(27)15-19/h3-4,15,17H,5-14,16,18H2,1-2H3,(H,28,35)(H,29,30,31) WXVWOXLABRWNAU-UHFFFAOYSA-N 235762 US9359371, 46 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 0.31 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235762&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214470 340129355 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410680 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1F InChI=1S/C24H30FN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- UVHCAAMIPBBEQO-VNGAXPGBSA-N 235764 US9359371, 48 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 7.99 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235764&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214251 340129357 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410681 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1C InChI=1S/C25H33N5O3/c1-15-9-16(3-8-22(15)33-2)11-26-23-21(24(32)28-19-4-6-20(31)7-5-19)12-27-25(29-23)30-13-17-10-18(17)14-30/h3,8-9,12,17-20,31H,4-7,10-11,13-14H2,1-2H3,(H,28,32)(H,26,27,29)/t17?,18?,19-,20- IEZYPHZUBOUHML-FOUKWCRFSA-N 235765 US9359371, 50 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 7.72 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235765&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214253 340129358 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410682 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H30ClN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- NKAVILAJSNUOES-VNGAXPGBSA-N 235742 US9359371, 11 cGMP-specific 3',5'-cyclic phosphodiesterase [537-875] Human 0.41 7.5 US Patent 10.7270/Q2BR8R2B aid1803047 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10156&target=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235742&enzyme=cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+%5B537-875%5D&column=ki&startPg=0&Increment=50&submit=Search 73214113 340129335 1 TRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN 1RKP,1T9R,1UDT,1UDU,1UHO,2H40,2H42,2H44,3B2R,3BJC,3SHY,3SHZ,3SIE,4G2W,4G2Y,4I9Z,4IA0,4MD6,4OEW,4OEX,5ZZ2,6ACB,6IWI,6L6E,6VBI,7FAQ,7FAR cGMP-specific 3',5'-cyclic phosphodiesterase PDE5A_HUMAN O76074 A0AV69 A8K2C4 O75026 O75887 Q86UI0 Q86V66 Q9Y6Z6 410683 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccc2)N2CC3CC3C2)cc1Cl InChI=1S/C25H26ClN5O2/c1-33-22-8-7-17(9-21(22)26)12-27-23-20(24(32)28-11-16-5-3-2-4-6-16)13-29-25(30-23)31-14-18-10-19(18)15-31/h2-9,13,18-19H,10-12,14-15H2,1H3,(H,28,32)(H,27,29,30) QFAMNDUERIPOEM-UHFFFAOYSA-N 235735 US9359371, 3 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Bovine 8.89 7.5 US Patent 10.7270/Q2BR8R2B aid1803048 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10157&target=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235735&enzyme=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 73214473 340129328 1 MGEVTAEEVEKFLDSNVSFAKQYYNLRYRAKVISDLLGPREAAVDFSNYHALNSVEESEIIFDLLRDFQDNLQAEKCVFNVMKKLCFLLQADRMSLFMYRARNGIAELATRLFNVHKDAVLEECLVAPDSEIVFPLDMGVVGHVALSKKIVNVPNTEEDEHFCDFVDTLTEYQTKNILASPIMNGKDVVAIIMVVNKVDGPHFTENDEEILLKYLNFANLIMKVFHLSYLHNCETRRGQILLWSGSKVFEELTDIERQFHKALYTVRAFLNCDRYSVGLLDMTKQKEFFDVWPVLMGEAPPYAGPRTPDGREINFYKVIDYILHGKEDIKVIPNPPPDHWALVSGLPTYVAQNGLICNIMNAPSEDFFAFQKEPLDESGWMIKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEMDETLMESLTQFLGWSVLNPDTYELMNKLENRKDIFQDMVKYHVKCDNEEIQTILKTREVYGKEPWECEEEELAEILQGELPDADKYEINKFHFSDLPLTELELVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYRRITYHNWRHGFNVGQTMFSLLVTGKLKRYFTDLEALAMVTAAFCHDIDHRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKTLLRDESLNIFQNLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYETQQEWTQYMMLDQTRKEIVMAMMMTACDLSAITKPWEVQSKVALLVAAEFWEQGDLERTVLQQNPIPMMDRNKADELPKLQVGFIDFVCTFVYKEFSRFHEEITPMLDGITNNRKEWKALADEYETKMKGLEEEKQKQQAANQAAAGSQHGGKQPGGGPASKSCCVQ 6MZB,7JSN Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha PDE6A_BOVIN P11541 410684 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H30ClN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- NKAVILAJSNUOES-VNGAXPGBSA-N 235742 US9359371, 11 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Bovine 61 7.5 US Patent 10.7270/Q2BR8R2B aid1803048 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10157&target=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235742&enzyme=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 73214113 340129335 1 MGEVTAEEVEKFLDSNVSFAKQYYNLRYRAKVISDLLGPREAAVDFSNYHALNSVEESEIIFDLLRDFQDNLQAEKCVFNVMKKLCFLLQADRMSLFMYRARNGIAELATRLFNVHKDAVLEECLVAPDSEIVFPLDMGVVGHVALSKKIVNVPNTEEDEHFCDFVDTLTEYQTKNILASPIMNGKDVVAIIMVVNKVDGPHFTENDEEILLKYLNFANLIMKVFHLSYLHNCETRRGQILLWSGSKVFEELTDIERQFHKALYTVRAFLNCDRYSVGLLDMTKQKEFFDVWPVLMGEAPPYAGPRTPDGREINFYKVIDYILHGKEDIKVIPNPPPDHWALVSGLPTYVAQNGLICNIMNAPSEDFFAFQKEPLDESGWMIKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEMDETLMESLTQFLGWSVLNPDTYELMNKLENRKDIFQDMVKYHVKCDNEEIQTILKTREVYGKEPWECEEEELAEILQGELPDADKYEINKFHFSDLPLTELELVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYRRITYHNWRHGFNVGQTMFSLLVTGKLKRYFTDLEALAMVTAAFCHDIDHRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKTLLRDESLNIFQNLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYETQQEWTQYMMLDQTRKEIVMAMMMTACDLSAITKPWEVQSKVALLVAAEFWEQGDLERTVLQQNPIPMMDRNKADELPKLQVGFIDFVCTFVYKEFSRFHEEITPMLDGITNNRKEWKALADEYETKMKGLEEEKQKQQAANQAAAGSQHGGKQPGGGPASKSCCVQ 6MZB,7JSN Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha PDE6A_BOVIN P11541 410685 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H32ClN5O3/c1-34-21-7-2-16(12-20(21)26)13-27-22-19(23(33)29-17-3-5-18(32)6-4-17)14-28-24(30-22)31-11-10-25(15-31)8-9-25/h2,7,12,14,17-18,32H,3-6,8-11,13,15H2,1H3,(H,29,33)(H,27,28,30)/t17-,18- SYXJXPIARFJMEF-IYARVYRRSA-N 235755 US9359371, 38 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Bovine 58 7.5 US Patent 10.7270/Q2BR8R2B aid1803048 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10157&target=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235755&enzyme=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 73214182 340129348 1 MGEVTAEEVEKFLDSNVSFAKQYYNLRYRAKVISDLLGPREAAVDFSNYHALNSVEESEIIFDLLRDFQDNLQAEKCVFNVMKKLCFLLQADRMSLFMYRARNGIAELATRLFNVHKDAVLEECLVAPDSEIVFPLDMGVVGHVALSKKIVNVPNTEEDEHFCDFVDTLTEYQTKNILASPIMNGKDVVAIIMVVNKVDGPHFTENDEEILLKYLNFANLIMKVFHLSYLHNCETRRGQILLWSGSKVFEELTDIERQFHKALYTVRAFLNCDRYSVGLLDMTKQKEFFDVWPVLMGEAPPYAGPRTPDGREINFYKVIDYILHGKEDIKVIPNPPPDHWALVSGLPTYVAQNGLICNIMNAPSEDFFAFQKEPLDESGWMIKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEMDETLMESLTQFLGWSVLNPDTYELMNKLENRKDIFQDMVKYHVKCDNEEIQTILKTREVYGKEPWECEEEELAEILQGELPDADKYEINKFHFSDLPLTELELVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYRRITYHNWRHGFNVGQTMFSLLVTGKLKRYFTDLEALAMVTAAFCHDIDHRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKTLLRDESLNIFQNLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYETQQEWTQYMMLDQTRKEIVMAMMMTACDLSAITKPWEVQSKVALLVAAEFWEQGDLERTVLQQNPIPMMDRNKADELPKLQVGFIDFVCTFVYKEFSRFHEEITPMLDGITNNRKEWKALADEYETKMKGLEEEKQKQQAANQAAAGSQHGGKQPGGGPASKSCCVQ 6MZB,7JSN Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha PDE6A_BOVIN P11541 410686 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCN(C)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C26H36ClN7O2/c1-32-11-13-33(14-12-32)10-8-28-24(35)20-17-30-25(34-9-7-26(18-34)5-6-26)31-23(20)29-16-19-3-4-22(36-2)21(27)15-19/h3-4,15,17H,5-14,16,18H2,1-2H3,(H,28,35)(H,29,30,31) WXVWOXLABRWNAU-UHFFFAOYSA-N 235762 US9359371, 46 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Bovine 310 7.5 US Patent 10.7270/Q2BR8R2B aid1803048 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10157&target=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235762&enzyme=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 73214470 340129355 1 MGEVTAEEVEKFLDSNVSFAKQYYNLRYRAKVISDLLGPREAAVDFSNYHALNSVEESEIIFDLLRDFQDNLQAEKCVFNVMKKLCFLLQADRMSLFMYRARNGIAELATRLFNVHKDAVLEECLVAPDSEIVFPLDMGVVGHVALSKKIVNVPNTEEDEHFCDFVDTLTEYQTKNILASPIMNGKDVVAIIMVVNKVDGPHFTENDEEILLKYLNFANLIMKVFHLSYLHNCETRRGQILLWSGSKVFEELTDIERQFHKALYTVRAFLNCDRYSVGLLDMTKQKEFFDVWPVLMGEAPPYAGPRTPDGREINFYKVIDYILHGKEDIKVIPNPPPDHWALVSGLPTYVAQNGLICNIMNAPSEDFFAFQKEPLDESGWMIKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEMDETLMESLTQFLGWSVLNPDTYELMNKLENRKDIFQDMVKYHVKCDNEEIQTILKTREVYGKEPWECEEEELAEILQGELPDADKYEINKFHFSDLPLTELELVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYRRITYHNWRHGFNVGQTMFSLLVTGKLKRYFTDLEALAMVTAAFCHDIDHRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKTLLRDESLNIFQNLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYETQQEWTQYMMLDQTRKEIVMAMMMTACDLSAITKPWEVQSKVALLVAAEFWEQGDLERTVLQQNPIPMMDRNKADELPKLQVGFIDFVCTFVYKEFSRFHEEITPMLDGITNNRKEWKALADEYETKMKGLEEEKQKQQAANQAAAGSQHGGKQPGGGPASKSCCVQ 6MZB,7JSN Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha PDE6A_BOVIN P11541 410687 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1F InChI=1S/C24H30FN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- UVHCAAMIPBBEQO-VNGAXPGBSA-N 235764 US9359371, 48 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Bovine 1110 7.5 US Patent 10.7270/Q2BR8R2B aid1803048 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10157&target=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235764&enzyme=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 73214251 340129357 1 MGEVTAEEVEKFLDSNVSFAKQYYNLRYRAKVISDLLGPREAAVDFSNYHALNSVEESEIIFDLLRDFQDNLQAEKCVFNVMKKLCFLLQADRMSLFMYRARNGIAELATRLFNVHKDAVLEECLVAPDSEIVFPLDMGVVGHVALSKKIVNVPNTEEDEHFCDFVDTLTEYQTKNILASPIMNGKDVVAIIMVVNKVDGPHFTENDEEILLKYLNFANLIMKVFHLSYLHNCETRRGQILLWSGSKVFEELTDIERQFHKALYTVRAFLNCDRYSVGLLDMTKQKEFFDVWPVLMGEAPPYAGPRTPDGREINFYKVIDYILHGKEDIKVIPNPPPDHWALVSGLPTYVAQNGLICNIMNAPSEDFFAFQKEPLDESGWMIKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEMDETLMESLTQFLGWSVLNPDTYELMNKLENRKDIFQDMVKYHVKCDNEEIQTILKTREVYGKEPWECEEEELAEILQGELPDADKYEINKFHFSDLPLTELELVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYRRITYHNWRHGFNVGQTMFSLLVTGKLKRYFTDLEALAMVTAAFCHDIDHRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKTLLRDESLNIFQNLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYETQQEWTQYMMLDQTRKEIVMAMMMTACDLSAITKPWEVQSKVALLVAAEFWEQGDLERTVLQQNPIPMMDRNKADELPKLQVGFIDFVCTFVYKEFSRFHEEITPMLDGITNNRKEWKALADEYETKMKGLEEEKQKQQAANQAAAGSQHGGKQPGGGPASKSCCVQ 6MZB,7JSN Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha PDE6A_BOVIN P11541 410688 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1C InChI=1S/C25H33N5O3/c1-15-9-16(3-8-22(15)33-2)11-26-23-21(24(32)28-19-4-6-20(31)7-5-19)12-27-25(29-23)30-13-17-10-18(17)14-30/h3,8-9,12,17-20,31H,4-7,10-11,13-14H2,1-2H3,(H,28,32)(H,26,27,29)/t17?,18?,19-,20- IEZYPHZUBOUHML-FOUKWCRFSA-N 235765 US9359371, 50 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Bovine 660 7.5 US Patent 10.7270/Q2BR8R2B aid1803048 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=10157&target=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235765&enzyme=Rod+cGMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+subunit+alpha&column=ki&startPg=0&Increment=50&submit=Search 73214253 340129358 1 MGEVTAEEVEKFLDSNVSFAKQYYNLRYRAKVISDLLGPREAAVDFSNYHALNSVEESEIIFDLLRDFQDNLQAEKCVFNVMKKLCFLLQADRMSLFMYRARNGIAELATRLFNVHKDAVLEECLVAPDSEIVFPLDMGVVGHVALSKKIVNVPNTEEDEHFCDFVDTLTEYQTKNILASPIMNGKDVVAIIMVVNKVDGPHFTENDEEILLKYLNFANLIMKVFHLSYLHNCETRRGQILLWSGSKVFEELTDIERQFHKALYTVRAFLNCDRYSVGLLDMTKQKEFFDVWPVLMGEAPPYAGPRTPDGREINFYKVIDYILHGKEDIKVIPNPPPDHWALVSGLPTYVAQNGLICNIMNAPSEDFFAFQKEPLDESGWMIKNVLSMPIVNKKEEIVGVATFYNRKDGKPFDEMDETLMESLTQFLGWSVLNPDTYELMNKLENRKDIFQDMVKYHVKCDNEEIQTILKTREVYGKEPWECEEEELAEILQGELPDADKYEINKFHFSDLPLTELELVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYRRITYHNWRHGFNVGQTMFSLLVTGKLKRYFTDLEALAMVTAAFCHDIDHRGTNNLYQMKSQNPLAKLHGSSILERHHLEFGKTLLRDESLNIFQNLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYETQQEWTQYMMLDQTRKEIVMAMMMTACDLSAITKPWEVQSKVALLVAAEFWEQGDLERTVLQQNPIPMMDRNKADELPKLQVGFIDFVCTFVYKEFSRFHEEITPMLDGITNNRKEWKALADEYETKMKGLEEEKQKQQAANQAAAGSQHGGKQPGGGPASKSCCVQ 6MZB,7JSN Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha PDE6A_BOVIN P11541 410689 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CC3CC3C2)cc1Cl InChI=1S/C23H24ClN7O2/c1-33-19-4-3-14(7-18(19)24)9-27-21-17(22(32)28-11-20-25-5-2-6-26-20)10-29-23(30-21)31-12-15-8-16(15)13-31/h2-7,10,15-16H,8-9,11-13H2,1H3,(H,28,32)(H,27,29,30) MZTKPBZVHILACH-UHFFFAOYSA-N 235733 US9359371, 1 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235733&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214471 340129326 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410690 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccccn2)N2CC3CC3C2)cc1Cl InChI=1S/C24H25ClN6O2/c1-33-21-6-5-15(8-20(21)25)10-27-22-19(23(32)28-11-18-4-2-3-7-26-18)12-29-24(30-22)31-13-16-9-17(16)14-31/h2-8,12,16-17H,9-11,13-14H2,1H3,(H,28,32)(H,27,29,30) BCJVQQJQFQTUGB-UHFFFAOYSA-N 235734 US9359371, 2 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235734&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214472 340129327 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410691 COc1ccc(CNc2nc(ncc2C(=O)NCc2cnc(C)cn2)N2CC3CC3C2)cc1Cl InChI=1S/C24H26ClN7O2/c1-14-7-27-18(9-26-14)10-29-23(33)19-11-30-24(32-12-16-6-17(16)13-32)31-22(19)28-8-15-3-4-21(34-2)20(25)5-15/h3-5,7,9,11,16-17H,6,8,10,12-13H2,1-2H3,(H,29,33)(H,28,30,31) YTGPPIXKPISAKT-UHFFFAOYSA-N 235736 US9359371, 4 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235736&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214543 340129329 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410692 COc1ccc(CNc2nc(ncc2C(=O)NCc2ccc(F)cc2)N2CC3CC3C2)cc1Cl InChI=1S/C25H25ClFN5O2/c1-34-22-7-4-16(8-21(22)26)11-28-23-20(24(33)29-10-15-2-5-19(27)6-3-15)12-30-25(31-23)32-13-17-9-18(17)14-32/h2-8,12,17-18H,9-11,13-14H2,1H3,(H,29,33)(H,28,30,31) UXSJCOGGAQEECN-UHFFFAOYSA-N 235737 US9359371, 5 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235737&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214544 340129330 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410693 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCOCC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H31ClN6O3/c1-33-21-3-2-16(10-20(21)25)12-27-22-19(23(32)26-4-5-30-6-8-34-9-7-30)13-28-24(29-22)31-14-17-11-18(17)15-31/h2-3,10,13,17-18H,4-9,11-12,14-15H2,1H3,(H,26,32)(H,27,28,29) JYGJLOZZTXETOG-UHFFFAOYSA-N 235738 US9359371, 6 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235738&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214321 340129331 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410694 COc1ccc(CNc2nc(ncc2C(=O)NCC2CCNCC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H31ClN6O2/c1-33-21-3-2-16(8-20(21)25)11-27-22-19(23(32)28-10-15-4-6-26-7-5-15)12-29-24(30-22)31-13-17-9-18(17)14-31/h2-3,8,12,15,17-18,26H,4-7,9-11,13-14H2,1H3,(H,28,32)(H,27,29,30) MNEFEOJKLYSCJF-UHFFFAOYSA-N 235739 US9359371, 7 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235739&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214322 340129332 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410695 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CCCCNC2=O)N2CC3CC3C2)cc1Cl InChI=1S/C24H29ClN6O3/c1-34-20-6-5-14(8-18(20)25)10-27-21-17(22(32)29-19-4-2-3-7-26-23(19)33)11-28-24(30-21)31-12-15-9-16(15)13-31/h5-6,8,11,15-16,19H,2-4,7,9-10,12-13H2,1H3,(H,26,33)(H,29,32)(H,27,28,30)/t15?,16?,19-/m0/s1 WZVAWCCERLVMTA-RJYAGPCLSA-N 235740 US9359371, 8 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235740&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214392 340129333 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410696 COc1ccc(CNc2nc(ncc2C(=O)NC2CCCCCC2)N2CC3CC3C2)cc1Cl InChI=1S/C25H32ClN5O2/c1-33-22-9-8-16(10-21(22)26)12-27-23-20(24(32)29-19-6-4-2-3-5-7-19)13-28-25(30-23)31-14-17-11-18(17)15-31/h8-10,13,17-19H,2-7,11-12,14-15H2,1H3,(H,29,32)(H,27,28,30) FOCZLKMINJBXND-UHFFFAOYSA-N 235741 US9359371, 9 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235741&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214115 340129334 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410697 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](O)CC2)N2CC3CC3C2)cc1Cl InChI=1S/C24H30ClN5O3/c1-33-21-7-2-14(8-20(21)25)10-26-22-19(23(32)28-17-3-5-18(31)6-4-17)11-27-24(29-22)30-12-15-9-16(15)13-30/h2,7-8,11,15-18,31H,3-6,9-10,12-13H2,1H3,(H,28,32)(H,26,27,29)/t15?,16?,17-,18- NKAVILAJSNUOES-VNGAXPGBSA-N 235742 US9359371, 11 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235742&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214113 340129335 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410698 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC3(CCC3)CC2)cc1Cl InChI=1S/C26H30ClN7O2/c1-36-21-5-4-18(14-20(21)27)15-30-23-19(24(35)31-17-22-28-10-3-11-29-22)16-32-25(33-23)34-12-8-26(9-13-34)6-2-7-26/h3-5,10-11,14,16H,2,6-9,12-13,15,17H2,1H3,(H,31,35)(H,30,32,33) QMKYSIPXVNLFRI-UHFFFAOYSA-N 235743 US9359371, 14 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235743&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214546 340129336 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410699 COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC3(CCN(C)C3)C2)cc1Cl InChI=1S/C26H31ClN8O2/c1-34-10-6-26(16-34)7-11-35(17-26)25-32-14-19(24(36)31-15-22-28-8-3-9-29-22)23(33-25)30-13-18-4-5-21(37-2)20(27)12-18/h3-5,8-9,12,14H,6-7,10-11,13,15-17H2,1-2H3,(H,31,36)(H,30,32,33) XMOXWHBNBWOGDY-UHFFFAOYSA-N 235745 US9359371, 18 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235745&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214617 340129338 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410700 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCNCC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H34ClN7O2/c1-35-21-3-2-18(14-20(21)26)15-29-22-19(23(34)28-9-13-32-11-7-27-8-12-32)16-30-24(31-22)33-10-6-25(17-33)4-5-25/h2-3,14,16,27H,4-13,15,17H2,1H3,(H,28,34)(H,29,30,31) QJWGZBGMJFDCJV-UHFFFAOYSA-N 235759 US9359371, 42 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235759&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214396 340129352 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410701 COc1ccc(CNc2nc(ncc2C(=O)N[C@H]2CC[C@H](N)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C25H33ClN6O2/c1-34-21-7-2-16(12-20(21)26)13-28-22-19(23(33)30-18-5-3-17(27)4-6-18)14-29-24(31-22)32-11-10-25(15-32)8-9-25/h2,7,12,14,17-18H,3-6,8-11,13,15,27H2,1H3,(H,30,33)(H,28,29,31)/t17-,18- HFRJKYSYQXQKQU-IYARVYRRSA-N 235761 US9359371, 44 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235761&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214183 340129354 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410702 COc1ccc(CNc2nc(ncc2C(=O)NCCN2CCN(C)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C26H36ClN7O2/c1-32-11-13-33(14-12-32)10-8-28-24(35)20-17-30-25(34-9-7-26(18-34)5-6-26)31-23(20)29-16-19-3-4-22(36-2)21(27)15-19/h3-4,15,17H,5-14,16,18H2,1-2H3,(H,28,35)(H,29,30,31) WXVWOXLABRWNAU-UHFFFAOYSA-N 235762 US9359371, 46 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235762&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214470 340129355 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45 410703 COc1ccc(CNc2nc(ncc2C(=O)NCC2CCC(O)CC2)N2CCC3(CC3)C2)cc1Cl InChI=1S/C26H34ClN5O3/c1-35-22-7-4-18(12-21(22)27)14-28-23-20(24(34)29-13-17-2-5-19(33)6-3-17)15-30-25(31-23)32-11-10-26(16-32)8-9-26/h4,7,12,15,17,19,33H,2-3,5-6,8-11,13-14,16H2,1H3,(H,29,34)(H,28,30,31) QNVSPXGOOGMOHU-UHFFFAOYSA-N 235763 US9359371, 47 Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A Human >10000 7.5 US Patent 10.7270/Q2BR8R2B aid1803049 US9359371 Wu, F; Wang, A 6/7/2016 7/3/2017 Xuanzhu Pharma Co., Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7417&target=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235763&enzyme=Dual+3%27%2C5%27-cyclic-AMP+and+-GMP+phosphodiesterase+11A&column=ki&startPg=0&Increment=50&submit=Search 73214250 340129356 1 MAASRLDFGEVETFLDRHPELFEDYLMRKGKQEMVEKWLQRHSQGQGALGPRPSLAGTSSLAHSTCRGGSSVGGGTGPNGSAHSQPLPGGGDCGGVPLSPSWAGGSRGDGNLQRRASQKELRKSFARSKAIHVNRTYDEQVTSRAQEPLSSVRRRALLRKASSLPPTTAHILSALLESRVNLPRYPPTAIDYKCHLKKHNERQFFLELVKDISNDLDLTSLSYKILIFVCLMVDADRCSLFLVEGAAAGKKTLVSKFFDVHAGTPLLPCSSTENSNEVQVPWGKGIIGYVGEHGETVNIPDAYQDRRFNDEIDKLTGYKTKSLLCMPIRSSDGEIIGVAQAINKIPEGAPFTEDDEKVMQMYLPFCGIAISNAQLFAASRKEYERSRALLEVVNDLFEEQTDLEKIVKKIMHRAQTLLKCERCSVLLLEDIESPVVKFTKSFELMSPKCSADAENSFKESMEKSSYSDWLINNSIAELVASTGLPVNISDAYQDPRFDAEADQISGFHIRSVLCVPIWNSNHQIIGVAQVLNRLDGKPFDDADQRLFEAFVIFCGLGINNTIMYDQVKKSWAKQSVALDVLSYHATCSKAEVDKFKAANIPLVSELAIDDIHFDDFSLDVDAMITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYRMVLYHNWRHAFNVCQLMFAMLTTAGFQDILTEVEILAVIVGCLCHDLDHRGTNNAFQAKSGSALAQLYGTSATLEHHHFNHAVMILQSEGHNIFANLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKGEYDWNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIFDRNRKDELPRLQLEWIDSICMPLYQALVKVNVKLKPMLDSVATNRSKWEELHQKRLLASTASSSPASVMVAKEDRN Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A PDE11_HUMAN Q9HCR9 Q14CD1 Q53T16 Q96S76 Q9GZY7 Q9HB46 Q9NY45